share_log

Amalgamated Bank Trims Holdings in Option Care Health, Inc. (NASDAQ:OPCH)

Amalgamated Bank Trims Holdings in Option Care Health, Inc. (NASDAQ:OPCH)

合併後的Bank Trims Holdings in Option Care Health,Inc.(納斯達克代碼:OPCH)
Defense World ·  2022/09/25 04:21

Amalgamated Bank lessened its holdings in shares of Option Care Health, Inc. (NASDAQ:OPCH – Get Rating) by 4.1% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 90,794 shares of the company's stock after selling 3,910 shares during the period. Amalgamated Bank's holdings in Option Care Health were worth $2,593,000 at the end of the most recent reporting period.

據Option Care Health,Inc.(納斯達克代碼:OPCH-GET評級)在最近提交給美國證券交易委員會(美國證券交易委員會)的文件中稱,合併後的銀行在第一季度減持了4.1%的股票。該公司持有90,794股該公司股票,在此期間出售了3,910股。在最近一次報告期結束時,合併銀行持有的期權Care Health價值2,593,000美元。

Other hedge funds also recently bought and sold shares of the company. State Street Corp boosted its position in Option Care Health by 3.0% during the 1st quarter. State Street Corp now owns 4,539,810 shares of the company's stock valued at $129,657,000 after acquiring an additional 133,504 shares in the last quarter. Bellevue Group AG boosted its position in Option Care Health by 10.6% during the 1st quarter. Bellevue Group AG now owns 3,232,787 shares of the company's stock valued at $92,328,000 after acquiring an additional 308,744 shares in the last quarter. Marshall Wace LLP bought a new stake in Option Care Health during the 4th quarter valued at approximately $85,991,000. Nuveen Asset Management LLC boosted its position in Option Care Health by 1.8% during the 4th quarter. Nuveen Asset Management LLC now owns 2,937,263 shares of the company's stock valued at $83,536,000 after acquiring an additional 53,279 shares in the last quarter. Finally, Geode Capital Management LLC boosted its position in Option Care Health by 7.1% during the 4th quarter. Geode Capital Management LLC now owns 2,688,710 shares of the company's stock valued at $76,466,000 after acquiring an additional 177,890 shares in the last quarter. Hedge funds and other institutional investors own 92.58% of the company's stock.

其他對衝基金最近也買賣了該公司的股票。道富集團在第一季度將其在Option Care Health的頭寸提高了3.0%。道富銀行目前持有該公司4,539,810股股票,價值129,657,000美元,上一季度又收購了133,504股。貝爾維尤集團第一季度將其在Option Care Health的頭寸提高了10.6%。貝爾維尤集團(Bellevue Group AG)在上個季度增持了308,744股後,目前擁有該公司3,232,787股股票,價值92,328,000美元。馬歇爾·華斯有限責任公司在第四季度購買了Option Care Health的新股份,價值約85,991,000美元。Nuveen Asset Management LLC在第四季度將其在Option Care Health的頭寸提高了1.8%。Nuveen Asset Management LLC在上個季度增持了53,279股後,現在擁有2,937,263股該公司的股票,價值83,536,000美元。最後,Geode Capital Management LLC在第四季度將其在Option Care Health的頭寸提高了7.1%。Geode Capital Management LLC現在擁有該公司2,688,710股股票,價值76,466,000美元,上個季度又收購了177,890股。對衝基金和其他機構投資者持有該公司92.58%的股票。

Get
到達
Option Care Health
Option Care Health
alerts:
警報:

Analyst Upgrades and Downgrades

分析師升級和下調評級

Several analysts have weighed in on OPCH shares. Lake Street Capital lifted their price objective on Option Care Health from $35.00 to $45.00 in a research report on Thursday, July 28th. The Goldman Sachs Group lifted their price objective on Option Care Health from $31.00 to $40.00 and gave the company a "buy" rating in a research report on Monday, August 22nd. Barrington Research boosted their price target on Option Care Health from $33.00 to $37.00 and gave the stock an "outperform" rating in a research report on Thursday, July 28th. Finally, TheStreet raised Option Care Health from a "c+" rating to a "b" rating in a research report on Monday, June 6th.

幾位分析師對OPCH的股票進行了加碼。在7月28日星期四的一份研究報告中,Lake Street Capital將Option Care Health的價格目標從35.00美元上調至45.00美元。8月22日,高盛夫婦在一份研究報告中將其期權醫療保健的目標價從31.00美元上調至40.00美元,並給予該公司“買入”評級。巴靈頓研究公司將其期權Care Health的目標價從33.00美元上調至37.00美元,並在7月28日星期四的一份研究報告中給予該股“跑贏大盤”的評級。最後,華爾街在6月6日星期一的一份研究報告中將選項Care Health的評級從“c+”上調至“b”。

Option Care Health Stock Performance

期權醫療保健股票表現

Shares of OPCH opened at $29.74 on Friday. The company has a quick ratio of 1.16, a current ratio of 1.58 and a debt-to-equity ratio of 0.82. The business's 50 day moving average price is $32.60 and its 200-day moving average price is $29.79. Option Care Health, Inc. has a 52 week low of $21.32 and a 52 week high of $35.57. The stock has a market cap of $5.41 billion, a P/E ratio of 30.66, a P/E/G ratio of 2.85 and a beta of 1.34.
週五,OPCH的股價開盤報29.74美元。該公司的速動比率為1.16,流動比率為1.58,債務權益比為0.82。該業務的50日移動均線價格為32.60美元,200日移動均線價格為29.79美元。Option Care Health,Inc.的52周低點為21.32美元,52周高位為35.57美元。該股市值為54.1億美元,市盈率為30.66倍,市盈率為2.85倍,貝塔係數為1.34。

Option Care Health (NASDAQ:OPCH – Get Rating) last released its quarterly earnings data on Wednesday, July 27th. The company reported $0.19 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.22 by ($0.03). The business had revenue of $980.80 million during the quarter, compared to the consensus estimate of $940.93 million. Option Care Health had a net margin of 4.71% and a return on equity of 12.11%. The business's revenue was up 14.0% compared to the same quarter last year. During the same period last year, the company posted $0.18 earnings per share. Equities research analysts anticipate that Option Care Health, Inc. will post 0.78 earnings per share for the current fiscal year.

Options Care Health(納斯達克:OPCH-GET Rating)最近一次發佈季度收益數據是在7月27日(星期三)。該公司公佈本季度每股收益(EPS)為0.19美元,低於市場普遍預期的0.22美元(0.03美元)。該業務本季度的收入為9.80億美元,而普遍預期為9.4093億美元。Option Care Health的淨利潤率為4.71%,股本回報率為12.11%。與去年同期相比,該業務的收入增長了14.0%。去年同期,該公司公佈的每股收益為0.18美元。股票研究分析師預計,期權Care Health,Inc.將公佈本財年每股收益0.78美元。

Insider Activity at Option Care Health

Option Care Health的內部活動

In related news, major shareholder Walgreens Boots Alliance, Inc. sold 11,000,000 shares of the company's stock in a transaction that occurred on Tuesday, August 16th. The stock was sold at an average price of $33.01, for a total value of $363,110,000.00. Following the transaction, the insider now directly owns 26,247,092 shares of the company's stock, valued at approximately $866,416,506.92. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other Option Care Health news, Director R Carter Pate sold 1,923 shares of the business's stock in a transaction on Friday, July 8th. The shares were sold at an average price of $30.00, for a total transaction of $57,690.00. Following the completion of the sale, the director now directly owns 101,304 shares in the company, valued at approximately $3,039,120. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, major shareholder Walgreens Boots Alliance, Inc. sold 11,000,000 shares of the business's stock in a transaction on Tuesday, August 16th. The shares were sold at an average price of $33.01, for a total transaction of $363,110,000.00. Following the sale, the insider now owns 26,247,092 shares of the company's stock, valued at $866,416,506.92. The disclosure for this sale can be found here. In the last three months, insiders have sold 11,003,846 shares of company stock valued at $363,231,861. 0.22% of the stock is owned by corporate insiders.

在相關新聞中,大股東Walgreens Boots Alliance,Inc.在8月16日星期二的一筆交易中出售了11,000,000股公司股票。這隻股票的平均售價為33.01美元,總價值為363,110,000.00美元。交易完成後,這位內部人士現在直接持有該公司26,247,092股股票,價值約866,416,506.92美元。這筆交易是在提交給美國證券交易委員會的一份法律文件中披露的,該文件可通過此超鏈接。在另一則期權Care Health的消息中,董事R卡特·佩特在7月8日(星期五)的一筆交易中出售了1,923股該公司的股票。這些股票的平均價格為30.00美元,總成交額為57690.00美元。出售完成後,董事現在直接擁有該公司101,304股,價值約3,039,120美元。這筆交易是在提交給美國證券交易委員會的一份文件中披露的,該文件可以通過這個環節。此外,大股東Walgreens Boots Alliance,Inc.在8月16日星期二的一次交易中出售了11,000,000股該公司的股票。這些股票以33.01美元的平均價格出售,總成交金額為363,110,000.00美元。出售後,這位內部人士現在擁有26,247,092股該公司股票,價值866,416,506.92美元。關於這次銷售的披露可以找到這裏。在過去三個月裏,內部人士出售了11,003,846股公司股票,價值363,231,861美元。0.22%的股份由企業內部人士持有。

Option Care Health Profile

選項護理健康配置文件

(Get Rating)

(獲取評級)

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.

Option Care Health,Inc.在美國提供家庭和備用地點輸液服務。該公司提供抗感染治療;治療心力衰竭的家庭輸液服務;治療中風、癌症和胃腸道疾病等多種急慢性疾病的家庭非腸道營養和腸內營養支持服務;治療免疫缺陷的免疫球蛋白輸注療法;以及治療慢性炎症性疾病的治療,包括克羅恩病、斑塊狀牛皮癬、牛皮癬關節炎、類風濕性關節炎、潰瘍性結腸炎和其他慢性炎症性疾病。

Further Reading

進一步閲讀

  • Get a free copy of the StockNews.com research report on Option Care Health (OPCH)
  • Will Wall Street's Enthusiasm About Datadog Lead To Big Gains?
  • MarketBeat: Week in Review 9/19 – 9/23
  • Why Does Tesla Stock Remain Resilient?
  • Is Costco's Post-Earnings Price Weakness A Good Time To Buy?
  • Are Layoffs At A Small-Cap Tech A Bellwether For Housing Stocks?
  • 免費獲取StockNews.com關於選項護理健康(OPCH)的研究報告
  • 華爾街對Datadog的熱情會帶來巨大的收益嗎?
  • MarketBeat:回顧一週9/19-9/23
  • 為什麼特斯拉的股票保持彈性?
  • 好市多盈利後價格疲軟是買入的好時機嗎?
  • 小盤股的裁員是樓市的晴雨表嗎?

Want to see what other hedge funds are holding OPCH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Option Care Health, Inc. (NASDAQ:OPCH – Get Rating).

想看看其他對衝基金持有OPCH嗎?訪問HoldingsChannel.com獲取Option Care Health,Inc.(納斯達克代碼:OPCH-GET Rating)的最新13F備案文件和內幕交易信息。

Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter.

接受《每日健康選擇》的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊,接收對Option Care Health和相關公司的最新新聞和分析師評級的簡要每日摘要。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論